MARGOT CHADWICK: Open Payments
NPI 1619213451 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,449 in 63 payments from 10 companies in 2025. Trend: 2023 $2,006 · 2024 $2,673 · 2025 $2,449
Food & beverage: $2,296Education: $153
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $610 |
| Otsuka America Pharmaceutical, Inc. | 11 | $434 |
| Alkermes, Inc. | 13 | $357 |
| Teva Pharmaceuticals USA, Inc. | 10 | $323 |
| Neurocrine BioSciences, Inc. | 5 | $232 |
| E.R. Squibb & Sons, L.L.C. | 8 | $220 |
| Vanda Pharmaceuticals Inc. | 1 | $108 |
| Axsome Therapeutics, Inc. | 1 | $104 |
| Lundbeck LLC | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: CAPLYTA, REXULTI, ARISTADA, INGREZZA, COBENFY, ABILIFY MAINTENA, AUSTEDO XR, LYBALVI.
Industry payments across MI — which companies pay providers there.
